Abstract
Hepatocellular carcinoma is a significant cause of mortality worldwide and a growing problem in the United States. Treatment options are often limited, and median survival is less than 1 year, Thus, prevention may provide the best opportunity to alter the natural history of this disease. Primary prevention is best exemplified by the successes of such public health measures as universal hepatitis B vaccination. Such antiviral therapies as interferon may also have a role. Lessons can be learned from complementary and alternative medicine, Nevertheless, more work is needed in understanding hepatocarcinogenesis and in developing models to assess potential chemopreventive agents. Copyright © 2004 by Current Science Inc.
Cite
CITATION STYLE
Fecht, W. J., & Befeler, A. S. (2004). Hepatocellular carcinoma: Updates in primary prevention. Current Gastroenterology Reports. Current Science Ltd. https://doi.org/10.1007/s11894-004-0024-3
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.